Loading...

GI Dynamics

BST:2GD
Snowflake Description

Limited growth with worrying balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
2GD
BST
A$21M
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

GI Dynamics, Inc., a medical device company, engages in the development, manufacture, and marketing of medical devices for non-surgical approaches to treat type 2 diabetes and obesity. The last earnings update was 4 days ago. More info.


Add to Portfolio Compare Print
  • GI Dynamics has significant price volatility in the past 3 months.
2GD Share Price and Events
7 Day Returns
14.3%
BST:2GD
3.2%
DE Medical Equipment
-0.2%
DE Market
1 Year Returns
-
BST:2GD
14.6%
DE Medical Equipment
-10.3%
DE Market
2GD Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
GI Dynamics (2GD) 14.3% -66.7% -55.6% - -20% -98.8%
DE Medical Equipment 3.2% 3.7% 7.8% 14.6% 109.1% 242%
DE Market -0.2% -2.4% 4% -10.3% 11.2% 10.8%
1 Year Return vs Industry and Market
  • No trading data on 2GD.
  • No trading data on 2GD.
Price Volatility
2GD
Industry
5yr Volatility vs Market

Value

 Is GI Dynamics undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.

In this section, we usually try to help investors determine whether GI Dynamics is trading at an attractive price based on the cash flow it is expected to produce in the future. But as GI Dynamics has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.

Show me the analysis anyway

INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for GI Dynamics. This is due to cash flow or dividend data being unavailable. The share price is €0.004.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for GI Dynamics's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are GI Dynamics's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BST:2GD PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in USD $-0.01
ASX:GID Share Price ** ASX (2019-05-20) in AUD A$0.02
ASX:GID Share Price converted to USD reporting currency Exchange rate (AUD/ USD) 0.691 $0.02
Germany Medical Equipment Industry PE Ratio Median Figure of 9 Publicly-Listed Medical Equipment Companies 36.34x
Germany Market PE Ratio Median Figure of 424 Publicly-Listed Companies 20.17x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of GI Dynamics.

BST:2GD PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ASX:GID Share Price ÷ EPS (both in USD)

= 0.02 ÷ -0.01

-1.38x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • GI Dynamics is loss making, we can't compare its value to the DE Medical Equipment industry average.
  • GI Dynamics is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does GI Dynamics's expected growth come at a high price?
Raw Data
BST:2GD PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -1.38x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
-23.6%per year
Germany Medical Equipment Industry PEG Ratio Median Figure of 6 Publicly-Listed Medical Equipment Companies 3.08x
Germany Market PEG Ratio Median Figure of 273 Publicly-Listed Companies 1.53x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for GI Dynamics, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on GI Dynamics's assets?
Raw Data
BST:2GD PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in USD $-0.01
ASX:GID Share Price * ASX (2019-05-20) in AUD A$0.02
ASX:GID Share Price converted to USD reporting currency Exchange rate (AUD/ USD) 0.691 $0.02
Germany Medical Equipment Industry PB Ratio Median Figure of 13 Publicly-Listed Medical Equipment Companies 4.25x
Germany Market PB Ratio Median Figure of 576 Publicly-Listed Companies 1.78x
BST:2GD PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ASX:GID Share Price ÷ Book Value per Share (both in USD)

= 0.02 ÷ -0.01

-2.56x

* Primary Listing of GI Dynamics.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • GI Dynamics has negative assets, we can't compare the value of its assets to the DE Medical Equipment industry average.

Next steps:

  1. Take a look at our analysis of 2GD’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through GI Dynamics's regulatory filings and announcements.
  3. Show me more potentially undervalued companies in the Medical Equipment industry
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Value checks
We assess GI Dynamics's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. GI Dynamics has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is GI Dynamics expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
-23.6%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is GI Dynamics expected to grow at an attractive rate?
  • Unable to compare GI Dynamics's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.
Growth vs Market Checks
  • Unable to compare GI Dynamics's earnings growth to the Germany market average as it is expected to be loss making during the next 1-3 years.
  • GI Dynamics's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
BST:2GD Future Growth Rates Data Sources
Data Point Source Value (per year)
BST:2GD Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts -23.6%
BST:2GD Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 89.8%
Germany Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 12.7%
Germany Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 6.2%
Germany Market Earnings Growth Rate Market Cap Weighted Average 13.1%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BST:2GD Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BST:2GD Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-12-31 0 -14 -18 1
2020-12-31 0 -11 -13 1
2019-12-31 0 -11 -12 1
BST:2GD Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-03-31 -9 -9
2018-12-31 -7 -8
2018-09-30 0 -8 -8
2018-06-30 0 -8 -9
2018-03-31 0 -9 -10
2017-12-31 0 -10 -11
2017-09-30 0 -10 -11
2017-06-30 0 -10 -11
2017-03-31 0 -12 -12
2016-12-31 1 -12 -13
2016-09-30 1 -15 -17
2016-06-30 1 -20 -22

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • GI Dynamics is not considered high growth as it is expected to be loss making for the next 1-3 years.
  • GI Dynamics's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BST:2GD Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from GI Dynamics Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BST:2GD Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-12-31 -0.30 -0.30 -0.30 1.00
2020-12-31 -0.30 -0.30 -0.30 1.00
2019-12-31 -0.40 -0.40 -0.40 1.00
BST:2GD Past Financials Data
Date (Data in USD Millions) EPS *
2019-03-31 -0.01
2018-12-31 -0.01
2018-09-30 -0.01
2018-06-30 -0.01
2018-03-31 -0.02
2017-12-31 -0.02
2017-09-30 -0.02
2017-06-30 -0.02
2017-03-31 -0.02
2016-12-31 -0.03
2016-09-30 -0.03
2016-06-30 -0.05

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if GI Dynamics will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess GI Dynamics's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
GI Dynamics has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has GI Dynamics performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare GI Dynamics's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • GI Dynamics does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare GI Dynamics's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare GI Dynamics's 1-year growth to the DE Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
GI Dynamics's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from GI Dynamics Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BST:2GD Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 -8.56 5.65 2.38
2018-12-31 -8.04 5.68 1.95
2018-09-30 -0.12 -8.26 5.86 1.71
2018-06-30 -0.10 -8.68 5.94 2.17
2018-03-31 -0.05 -10.00 6.74 2.91
2017-12-31 0.05 -10.89 6.76 3.56
2017-09-30 0.24 -11.29 7.10 3.95
2017-06-30 0.35 -11.44 7.31 3.95
2017-03-31 0.44 -12.38 7.47 4.06
2016-12-31 0.55 -13.12 8.40 3.85
2016-09-30 0.69 -16.57 8.69 5.41
2016-06-30 0.73 -21.91 10.17 8.21
2016-03-31 0.91 -28.25 11.96 11.74
2015-12-31 1.32 -35.16 13.44 16.54
2015-09-30 1.57 -42.77 16.17 21.00
2015-06-30 2.01 -46.81 17.98 24.07
2015-03-31 2.54 -48.87 19.48 26.96
2014-12-31 2.83 -48.21 20.28 26.65
2014-09-30 3.42 -43.22 20.22 23.80
2014-06-30 3.30 -39.22 19.86 20.85
2014-03-31 2.81 -36.55 19.43 16.80
2013-12-31 2.26 -35.58 19.94 14.68
2013-09-30 1.42 -34.30 20.18 13.78
2013-06-30 1.14 -34.01 20.67 13.11
2013-03-31 0.91 -29.94 19.47 12.17
2012-12-31 0.67 -26.79 17.97 11.47
2012-09-30 0.54 -26.59 17.16 10.37
2012-06-30 0.40 -26.39 16.35 9.27

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if GI Dynamics has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.
  • It is difficult to establish if GI Dynamics has efficiently used its assets last year compared to the DE Medical Equipment industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if GI Dynamics improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.
X
Past performance checks
We assess GI Dynamics's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
GI Dynamics has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is GI Dynamics's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up GI Dynamics's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • GI Dynamics's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • GI Dynamics's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of GI Dynamics's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • GI Dynamics has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from GI Dynamics Company Filings, last reported 1 month ago.

BST:2GD Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 -5.72 5.31 1.29
2018-12-31 -3.45 5.13 3.81
2018-09-30 -3.90 5.08 3.10
2018-06-30 -3.84 4.99 2.66
2018-03-31 -3.99 4.95 2.56
2017-12-31 -3.72 4.47 3.03
2017-09-30 -1.11 4.91 5.51
2017-06-30 1.42 4.92 8.02
2017-03-31 4.24 0.12 5.37
2016-12-31 6.79 0.21 8.29
2016-09-30 8.79 0.31 9.66
2016-06-30 11.44 0.00 12.25
2016-03-31 15.11 0.00 15.63
2015-12-31 18.26 0.00 19.59
2015-09-30 24.01 0.00 24.44
2015-06-30 31.21 0.00 32.82
2015-03-31 40.53 0.00 40.02
2014-12-31 50.18 0.00 51.19
2014-09-30 62.95 0.00 61.19
2014-06-30 73.92 0.02 71.67
2014-03-31 54.25 0.04 49.49
2013-12-31 62.39 0.06 58.62
2013-09-30
2013-06-30 25.58 0.09 22.39
2013-03-31 41.71 0.13 41.48
2012-12-31 41.71 0.13 41.48
2012-09-30 41.71 0.13 41.48
2012-06-30 55.91 0.14 55.38
  • GI Dynamics has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.
  • Irrelevant to check if GI Dynamics's debt level has increased considering it has negative shareholder equity.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • GI Dynamics has less than a year of cash runway based on current free cash flow.
  • GI Dynamics has less than a year of cash runway if free cash flow continues to reduce at historical rates of -37.5% each year.
X
Financial health checks
We assess GI Dynamics's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. GI Dynamics has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is GI Dynamics's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from GI Dynamics dividends.
If you bought €2,000 of GI Dynamics shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate GI Dynamics's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate GI Dynamics's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BST:2GD Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
Germany Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 8 Stocks 1.4%
Germany Market Average Dividend Yield Market Cap Weighted Average of 326 Stocks 3.1%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.5%
Germany Top 25% Dividend Yield 75th Percentile 3.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

BST:2GD Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2021-12-31
2020-12-31
2019-12-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as GI Dynamics has not reported any payouts.
  • Unable to verify if GI Dynamics's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of GI Dynamics's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as GI Dynamics has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess GI Dynamics's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can GI Dynamics afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. GI Dynamics has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of GI Dynamics's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Scott Schorer
COMPENSATION $533,068
AGE 50
TENURE AS CEO 3.2 years
CEO Bio

Mr. Scott W. Schorer has been the Chief Executive Officer and President of GI Dynamics, Inc. since March 2016. Mr. Schorer served as the Chief Executive Officer of PlasmaTech Biopharmaceuticals, Inc. since September 19, 2014 until June 2015. Mr. Schorer ran an Interim leadership and strategic consulting practice under the name of SSMC since May 2010 to September 2014. Mr. Schorer serves as a Venture Partner at Slater Technology Fund. He served as Managing Director with Plasma Technologies LLC since June 1, 2014. He has served over 20 years in a variety of Senior management and Board positions, including as Chief Executive Officer and President and has experience in all aspects of operations including research and development, intellectual property, manufacturing, sales and marketing. Additionally, Mr. Schorer has extensive experience as advisor to operating companies, venture capital firms and private equity firms. He served as President of the Americas at Systagenix Wound Management from February 2009 to May 2010. Mr. Schorer founded and led Innovative Spinal Technologies, where he served as the Chief Executive Officer and President since January 2003 until February 2009. He co-founded CentriMed and served as its Chief Executive Officer and President. He sold CentriMed to Global Healthcare Exchange in September 2000 and worked for GHX as Vice President of Business Development & Program Management. Mr. Schorer led the turnaround effort at Systagenix Wound Management since February 2009 until May 2010, the former Advanced Wound Care division of Johnson & Johnson as President of the Americas. Mr. Schorer served as a Leading Sales Representative and Trainer in the spinal and cranial surgery markets for Carl Zeiss, Leibinger, Anspach, Blackstone and Sugita. He served as an Infantry Platoon Leader in the United States Army as an Airborne Ranger in the 82nd Airborne Division. Mr. Schorer trained at the National Training Center for the ‘96 US Olympic rowing team and was a Member of the ‘95 US Rowing World Championship team. He served as a Director of Innovative Spinal Technologies Inc. and ProThera Biologics LLC. Mr. Schorer is also a co-inventor of 6 patents. Mr. Schorer holds a B.A. from Dartmouth College and B.E. from Thayer School of Engineering.

CEO Compensation
  • Scott's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Scott's remuneration is higher than average for companies of similar size in Germany.
Management Team

Scott Schorer

TITLE
CEO & President
COMPENSATION
$533K
AGE
50
TENURE
3.2 yrs

Charles Carter

TITLE
CFO, Treasurer & Secretary
TENURE
0.4 yrs

Keith Gersin

TITLE
Chief Medical Advisor

Manoel Neto

TITLE
Scientific Advisor of Gastroenterology & Member of Scientific Advisory Board
Board of Directors Tenure

Average tenure and age of the GI Dynamics board of directors in years:

2.2
Average Tenure
60.5
Average Age
  • The average tenure for the GI Dynamics board of directors is less than 3 years, this suggests a new board.
Board of Directors

Dan Moore

TITLE
Non-Executive Chairman
COMPENSATION
$76K
AGE
57
TENURE
3 yrs

Tim Barberich

TITLE
Non Executive Director
COMPENSATION
$63K
AGE
70
TENURE
7.9 yrs

Oern Stuge

TITLE
Non-Executive Director
COMPENSATION
$75K
AGE
64
TENURE
2.3 yrs

Juliet Thompson

TITLE
Non Executive Director
COMPENSATION
$73K
AGE
52
TENURE
1.8 yrs

Ricardo Cohen

TITLE
Member of Scientific Advisory Board
TENURE
2 yrs

Jan Greve

TITLE
Member of Scientific Advisory Board
TENURE
2.2 yrs

Manoel Neto

TITLE
Scientific Advisor of Gastroenterology & Member of Scientific Advisory Board
TENURE
2.2 yrs

Carel le Roux

TITLE
Member of Scientific Advisory Board
TENURE
2.2 yrs

David Cummings

TITLE
Member of Scientific Advisory Board
TENURE
2.2 yrs

Francesco Rubino

TITLE
Member of Scientific Advisory Board
TENURE
1.9 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess GI Dynamics's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. GI Dynamics has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

GI Dynamics, Inc., a medical device company, engages in the development, manufacture, and marketing of medical devices for non-surgical approaches to treat type 2 diabetes and obesity. The company offers EndoBarrier, a medical device for the treatment of patients with type 2 diabetes and obesity. It serves health care providers and third-party distributors. The company sells its products primarily in Europe, the Middle East, the Asia Pacific, and South America. GI Dynamics, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts.

Details
Name: GI Dynamics, Inc.
2GD
Exchange: BST
Founded: 2003
A$13,121,924
963,877,250
Website: http://www.gidynamics.com
Address: GI Dynamics, Inc.
PO Box 51915,
Boston,
Massachusetts, 02205,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ASX GID SHS CHESS DEP Australian Securities Exchange AU AUD 07. Sep 2011
OTCPK GIDY.L SHS CHESS DEP Pink Sheets LLC US USD 07. Sep 2011
DB 2GD SHS CHESS DEP Deutsche Boerse AG DE EUR 07. Sep 2011
BST 2GD SHS CHESS DEP Boerse-Stuttgart DE EUR 07. Sep 2011
CHIA GID SHS CHESS DEP Chi-X Australia AU AUD 07. Sep 2011
Number of employees
Current staff
Staff numbers
9
GI Dynamics employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/20 22:12
End of day share price update: 2019/05/20 00:00
Last estimates confirmation: 2019/04/02
Last earnings filing: 2019/05/16
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.